| INDICATION'S |
ONCOLOGY> - AdenoCarcinoma of Pancreas - Melanoma - Metastatic Renal Cell Carcinoma |
| MECHANISM OF ACTION | A5B1 Integrin Inhibition |
| STATUS | Phase II |
| UPDATE | 06.06.2006 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |